相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fragment-to-Lead Medicinal Chemistry Publications in 2016
Christopher N. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
Robert J. Young et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Current perspectives in fragment-based lead discovery (FBLD)
Bas Lamoree et al.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)
Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective
Maria Maddalena Cavalluzzi et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand Efficiency
Charles H. Reynolds et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations
Zoe Cournia et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
The influence of hydrogen bonding on partition coefficients
Nadia Melo Borges et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2017)
How Nothing Boosts Affinity: Hydrophobic Ligand Binding to the Virtually Vacated S1′ Pocket of Thermolysin
Stefan G. Krimmer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Beware of ligand efficiency (LE): understanding LE data in modeling structure-activity and structure-economy relationships
Jaroslaw Polanski et al.
JOURNAL OF CHEMINFORMATICS (2017)
N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry
Alessandra Ammazzalorso et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
A comparative study of warheads for design of cysteine protease inhibitors
Daniel G. Silva et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Quantifying, Visualizing, and Monitoring Lead Optimization
Andrew T. Maynard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
Bradley C. Doak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Debunking the Idea that Ligand Efficiency Indices Are Superior to pIC50 as QSAR Activities
Robert P. Sheridan
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
Gyoergy M. Keseru et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Elucidation of Nonadditive Effects in Protein-Ligand Binding Energies: Thrombin as a Case Study
Gaetano Calabro et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability
Laurie J. Gordon et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Molecular Recognition in Chemical and Biological Systems
Elke Persch et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Ligand efficiency metrics: why all the fuss?
Charles H. Reynolds
FUTURE MEDICINAL CHEMISTRY (2015)
Strong Nonadditivity as a Key Structure-Activity Relationship Feature: Distinguishing Structural Changes from Assay Artifacts
Christian Kramer et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Molecular Property Design: Does Everyone Get It?
Paul D. Leeson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Ligand efficiency metrics considered harmful
Peter W. Kenny et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Validity of Ligand Efficiency Metrics
Christopher W. Murray et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters
Michael D. Shultz
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inflation of correlation in the pursuit of drug-likeness
Peter W. Kenny et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Rapid Measurement of Intracellular Unbound Drug Concentrations
Andre Mateus et al.
MOLECULAR PHARMACEUTICS (2013)
Chemical predictive modelling to improve compound quality
John G. Cumming et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Duncan E. Scott et al.
BIOCHEMISTRY (2012)
Water Makes the Difference: Rearrangement of Water Solvation Layer Triggers Non-additivity of Functional Group Contributions in Protein-Ligand Binding
Adam Biela et al.
CHEMMEDCHEM (2012)
Exploring Activity Cliffs in Medicinal Chemistry Miniperspective
Dagmar Stumpfe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Alchemical free energy methods for drug discovery: progress and challenges
John D. Chodera et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Fragment screening to predict druggability (ligandability) and lead discovery success
Fredrik N. B. Edfeldt et al.
DRUG DISCOVERY TODAY (2011)
Can One Take the Logarithm or the Sine of a Dimensioned Quantity or a Unit? Dimensional Analysis Involving Transcendental Functions
Cherif F. Matta et al.
JOURNAL OF CHEMICAL EDUCATION (2011)
A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin Crystal Structures with Various Fragment Chemotypes
Helene Koester et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
Patrick C. May et al.
JOURNAL OF NEUROSCIENCE (2011)
Voodoo Correlations Are Everywhere-Not Only in Neuroscience
Klaus Fiedler
PERSPECTIVES ON PSYCHOLOGICAL SCIENCE (2011)
Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation
Cele Abad-Zapatero et al.
DRUG DISCOVERY TODAY (2010)
Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
Christopher W. Murray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Molecular Shape and Medicinal Chemistry: A Perspective
Anthony Nicholls et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Medicinal Chemist's Guide to Molecular Interactions
Caterina Bissantz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Non-additivity of Functional Group Contributions in Protein Ligand Binding: A Comprehensive Study by Crystallography and Isothermal Titration Calorimetry
Bernhard Baum et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Matched molecular pair analysis of activity and properties of glycogen phosphorylase inhibitors
Alan M. Birch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ
Lloyd G. Czaplewski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
Thomas Ryckmans et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Theory of Free Energy and Entropy in Noncovalent Binding
Huan-Xiang Zhou et al.
CHEMICAL REVIEWS (2009)
Design of compound libraries for fragment screening
Niklas Blomberg et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Calculation of Molecular Lipophilicity: State-of-the-Art and Comparison of Log P Methods on More Than 96,000 Compounds
Raimund Mannhold et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Group efficiency: A guideline for hits-to-leads chemistry
Marcel L. Verdonk et al.
CHEMMEDCHEM (2008)
Ligand binding efficiency: Trends, physical basis, and implications
Charles H. Reynolds et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency
Philip D. Edwards et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Discovery of a novel warhead against β-secretase through fragment-based lead generation
Stefan Geschwindner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Identification of inhibitors of protein kinase B using fragment-based lead discovery
Gordon Saxty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes
Jeffrey S. Albert et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Fragment-based drug design: How big is too big?
Philip J. Hajduk
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Fragment-based lead discovery: leads by design
RAE Carr et al.
DRUG DISCOVERY TODAY (2005)
5-substituted-1H-tetrazoles as carboxylic acid isosteres:: Medicinal chemistry and synthetic methods
RJ Herr
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations
MA McCoy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Is there a difference between leads and drugs? A historical perspective
TI Oprea et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Molecular complexity and its impact on the probability of finding leads for drug discovery
MM Hann et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Property-based design: Optimization of drug absorption and pharmacokinetics
H van de Waterbeemd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
HJ Boehm et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
